Urinary microbiota diversity and composition in patients with advanced renal cell cancer

Objectives: This study aims to investigate the role of urinary microbiota in renal cell carcinoma; we analysed urinary microbiota in kidney cancer patients and explored its potential role as biomarker. Subjects and methods: Samples were collected from 49 males (28 patients planned to undergo systemic therapy and 21 healthy volunteers). Two samples were collected from each patient, one prior to treatment and one after 8 to 12 weeks of systemic therapy. Microbiota was analysed by 16S rRNA sequencing. Microbiota diversity, taxonomic composition and relative abundance were compared between groups and longitudinal samples. Results: = 0.043) but not of treatment response. Conclusions: Urinary microbiota in patients with renal cell carcinoma differed from controls. Changes in microbiota composition were observed after systemic treatment. Urinary microbiota should be further investigated as a potential biomarker in renal cell carcinoma.

Authors

Institutions

Publication Details

Journal
BJUI Compass
Published
2026-05-01
DOI
https://doi.org/10.1002/bco2.70186
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urinary microbiota diversity and composition in patients with advanced renal cell cancer

Vitor Heidrich, Frederico Leal, R Kalil Filho, Denis L. F. Jardim et al.
BJUI Compass
Gut microbiota and health
article

Urinary microbiota diversity and composition in patients with advanced renal cell cancer

Vitor Heidrich, Frederico Leal, R Kalil Filho, Denis L. F. Jardim, Anamaria A. Camargo, Diogo A. Bastos, Ernande X. dos Santos, Lilian T. Inoue
article en

Abstract

Objectives: This study aims to investigate the role of urinary microbiota in renal cell carcinoma; we analysed urinary microbiota in kidney cancer patients and explored its potential role as biomarker. Subjects and methods: Samples were collected from 49 males (28 patients planned to undergo systemic therapy and 21 healthy volunteers). Two samples were collected from each patient, one prior to treatment and one after 8 to 12 weeks of systemic therapy. Microbiota was analysed by 16S rRNA sequencing. Microbiota diversity, taxonomic composition and relative abundance were compared between groups and longitudinal samples. Results: = 0.043) but not of treatment response. Conclusions: Urinary microbiota in patients with renal cell carcinoma differed from controls. Changes in microbiota composition were observed after systemic treatment. Urinary microbiota should be further investigated as a potential biomarker in renal cell carcinoma.

BJUI CompassVol. 7(5)
Universidade Estadual de Campinas (UNICAMP) (BR), University of Trento (IT), Hospital Sírio-Libanês (BR), Sociedade Brasileira de Oncologia Clínica (BR)
Ludwig Institute for Cancer Research
Openalex Percentile: Top 12%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.